Excess Mortality in New Zealand By Brian Simpson
John Gibson, an economics professor at the University of Waikato in Hamilton, New Zealand, has published a paper entitled, “The Rollout of COVID-19 Booster Vaccines is Associated with Rising Excess Mortality in New Zealand,” concluding the risks of the Covid vaccines outweigh any benefits. “The ratio of vaccine risk to benefits likely has swung more towards risk than during the original randomised trials, due to dose-dependent adverse events and to fixation of immune responses on a variant no longer circulating.” His study found that the age groups “most likely to use boosters had 7-10 percentage point rises in excess mortality rates as boosters were rolled out while the age group that is mostly too young for boosters saw no rise in excess mortality.” Extrapolating the study results worldwide, Gibson predicted 300,000 excess deaths, but many covid critics regard this figure as an under-estimation.
“A study based on weekly government data in New Zealand – one of the world's most vaccinated nations – found that the age groups most likely to have had COVID booster shots had up to 10% more excess deaths.
Excess mortality is the number of deaths from all causes above what would be typically expected in one year.
Authored by John Gibson, an economics professor at the University of Waikato in Hamilton, New Zealand, the study found there were 16 excess deaths per 100,000 booster doses in the country, amounting to more than 400 excess deaths, reported the website The Expose.
Gibson said that if extrapolated, it amounted to 300,000 excess deaths worldwide.
In his paper, "The Rollout of COVID-19 Booster Vaccines is Associated with Rising Excess Mortality in New Zealand," the economist said the bottom line from his study is that the risks of the COVID vaccines outweigh any benefits.
"The ratio of vaccine risk to benefits likely has swung more towards risk than during the original randomised trials, due to dose-dependent adverse events and to fixation of immune responses on a variant no longer circulating," he wrote.
The study found that the age groups "most likely to use boosters had 7-10 percentage point rises in excess mortality rates as boosters were rolled out while the age group that is mostly too young for boosters saw no rise in excess mortality.”
The Expose noted that last December, New Zealand’s COVID Response minister, Chris Hipkins, reduced the interval between the second dose and the booster shot from six months to four months. That made 82% of vaccinated New Zealanders eligible for a booster by late February 2022.Bottom of Form
A graph from Gibson's analysis shows a sustained rise in excess mortality coinciding with the booster rollout.
The increase in excess mortality over the past four months, the study found, was experienced by all ages except the 0-29 years group, who were mostly ineligible for boosters.
Gibson concluded the "age groups most likely to use boosters had 7–10 percentage point rises in excess mortality rates as boosters were rolled out while the age group that is mostly too young for boosters saw no rise in excess mortality."
https://expose-news.com/2022/07/07/study-10-rise-in-excess-mortality-after-boosters/
https://econpapers.repec.org/paper/waieconwp/22_2f11.htm
“Abstract: The rollout of booster doses of COVID-19 vaccines to the general population is controversial. The ratio of vaccine risk to benefits likely has swung more towards risk than during the original randomized trials, due to dose-dependent adverse events and to fixation of immune responses on a variant no longer circulating, yet the evidence underpinning mass use of boosters is weaker than was the evidence for the original vaccine rollout. In light of an unsatisfactory risk-evidence situation, aggregate weekly data on excess mortality in New Zealand are used here to study the impacts of rolling out booster doses. Instrumental variables estimates using a plausible source of exogenous variation in the rate of booster dose rollout indicate 16 excess deaths per 100,000 booster doses, totalling over 400 excess deaths from New Zealand's booster rollout to date. The value of statistical life of these excess deaths is over $1.6 billion. The age groups most likely to use boosters had 7-10 percentage point rises in excess mortality rates as boosters were rolled out while the age group that is mostly too young for boosters saw no rise in excess mortality.”
Comments